Biogen Inc (NASDAQ:BIIB)

223.51
Delayed Data
As of Oct 21
 +3.45 / +1.57%
Today’s Change
215.78
Today|||52-Week Range
344.00
-25.72%
Year-to-Date
Why Did the Market Whack This IPO?
Oct 14 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen vs. Gilead Sciences
Oct 10 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close220.06
Today’s open222.00
Day’s range221.56 - 225.78
Volume2,429,054
Average volume (3 months)1,556,955
Market cap$40.6B
Data as of 4:00pm ET, 10/21/2019

Growth & Valuation

Earnings growth (last year)+81.10%
Earnings growth (this year)+23.34%
Earnings growth (next 5 years)+2.84%
Revenue growth (last year)+9.67%
P/E ratio8.3
Price/Sales5.13
Price/Book3.33

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+4.39+1.42%
EXASExact Sciences Corp-3.68-3.81%
BMRNBiomarin Pharmaceuti...-0.73-1.06%
NBIXNeurocrine Bioscienc...+1.49+1.56%
Data as of 4:00pm ET, 10/21/2019

Financials

Last reporting dateOctober 22, 2019
EPS forecast (this quarter)$8.28
Annual revenue (last year)$12.1B
Annual profit (last year)$4.4B
Net profit margin36.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts